Overview
The specific aims of my recent research are to use ultrastructural and functional approaches to determine whether reactive oxygen species (ROS) are involved in Angiotensin II (AngII) signaling in well-characterized central autonomic neurons and to define their enzymatic source to determine whether NADPH oxidase is present in central autonomic neurons and, if so, whether NADPH oxidase-derived ROS are involved in the effects of AngII on these neurons. These studies focused on the dorsomedial nucleus of the solitary tract (dmNTS) because this region receives afferents from arterial baroreceptors and cardiopulmonary receptors via the vagus nerve, and is critical for maintaining cardiovascular homeostasis. Using double-label immunoelectronmicroscopy we have found that the essential NADPH oxidase subunit gp91phox is present in NTS neurons receiving vagal-like afferents that also contain AT1 receptors. In parallel experiments using electrophysiological approaches of dissociated dmNTS neurons anterogradely labeled via the vagus, I have found that AngII potentiates the L-type Ca2+ currents, an effect mediated by AT1 receptors and abolished by the ROS scavenger MnTBAP. The NADPH oxidase assembly inhibitor apocynin and the peptide inhibitor gp91ds, but not its scrambled version, also blocked the potentiation. The results provide evidence that NADPH oxidase-derived ROS are involved in the effects of AngII on Ca2+ signaling in dmNTS neurons receiving vagal afferents, and support the notion that ROS are important signaling molecules in central autonomic networks. For more information, please visit our website at:http://www.cornellneurology.org/neurobiology
Highlights
- 1Neuroscience · 2022
Publications
Funding
Active
5 grants- Co-IR01NS037853-27Alzheimer Pathology and Neurovascular DysfunctionNational Institute of Neurological Disorders and Stroke · 2017–2027· 2 renewals
- Co-IR01NS095441-06Dietary sodium, neurovascular dysfunction and cerebrovascular riskNational Institute of Neurological Disorders and Stroke · 2015–2027· 2 renewals
- Co-IR01NS126467-01ApoE4, neurovascular injury and cognitive impairmentNational Institute of Neurological Disorders and Stroke · 2022–2027
- Co-IR01HL136520-05A1Contribution of G Protein Coupled Estrogen Receptor to Changes in Hypothalamic Plasticity and Hypertension Susceptibility in Mice with Accelerated Ovarian FailureNational Heart, Lung, and Blood Institute · 2017–2026· 2 renewals
- Co-ICAF 233018-02Tau-induced postsynaptic dysfunction in tauopathy modelsCure Alzheimer’s Fund · 2023–2026
Completed grants (8)
- Co-IR01NS109588-05Role of CaMKII-alpha ubiquitination in ischemic strokeNational Institute of Neurological Disorders and Stroke · 2018–2024
- Co-IR01DA042943-05Aberrant Prefrontal Cortical Plasticity and Neurobehavioral Consequences of Adolescent MarijuanaNational Institute on Drug Abuse · 2017–2023
- Co-IR01AG070868-01Hypothalamic and metabolic dysfunction in Alzheimer's diseaseNational Institute on Aging · 2021–2023
- Co-IR01HL135498-04Hypothalamic Cytokines, Glutamate Receptor Plasticity, and Blood PressureNational Heart, Lung, and Blood Institute · 2017–2023
- Co-IR37NS089323-05Hypertension and neurovascular dysfunctionNational Institute of Neurological Disorders and Stroke · 2019–2023
- Co-IR01NS034179-26No Synthase Gene Expression and Cerebral Ischemic DamageNational Institute of Neurological Disorders and Stroke · 2017–2023
- Co-IR01NS100447-01ApoE4 and Mechanisms of Diffuse White Matter InjuryNational Institute of Neurological Disorders and Stroke · 2016–2022
- KPR01HL098351-04Menopausal Changes in Hypothalamus and Hypertension SusceptibilityNational Heart, Lung, and Blood Institute · 2011–2016